Burning Rock Biotech (BNR) links Form 6-K press release to F-3

Rhea-AI Filing Summary

Burning Rock Biotech Limited has furnished a Form 6-K as a foreign private issuer to provide a press release, filed as Exhibit 99.1. The company states that Exhibit 99.1, excluding the sections and table relating to non-GAAP measures, is incorporated by reference into its effective Form F-3 registration statement.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number: 001-39316

BURNING ROCK BIOTECH LIMITED

(Registrant’s Name)

No.5 Xingdao Ring Road North, International Bio Island

Guangzhou, Guangdong

People’s Republic of China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒    Form 40-F ☐

INCORPORATION BY REFERENCE

Exhibit 99.1 (excluding the paragraphs under the heading “Non-GAAP Measures,” the table under the heading “Burning Rock Biotech Limited Reconciliations of GAAP and Non-GAAP Results,” and other discussions on non-GAAP measures therein) of this current report on Form 6-K (the “Report”) shall be incorporated by reference into the Company’s registration statements on Form F-3, which became effective on September 30, 2022 (File no. 333-264577).

2

EXHIBIT INDEX

Number		Description of Document
Exhibit 99.1		Press release

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Burning Rock Biotech Limited
By:		/s/ Yusheng Han
Name:		Yusheng Han
Title:		Chief Executive officer

Date: September 8, 2025

4

FAQ

What did Burning Rock Biotech Limited (BNR) file in this Form 6-K?

Burning Rock Biotech Limited filed a Form 6-K as a foreign private issuer to furnish a press release as Exhibit 99.1. This exhibit, with certain non-GAAP content excluded, is linked to the company’s existing Form F-3 registration statement for reference purposes.

What is contained in Exhibit 99.1 to Burning Rock Biotech’s Form 6-K?

Exhibit 99.1 is a press release from Burning Rock Biotech Limited. The filing specifies that this exhibit, other than sections discussing non-GAAP measures and a related reconciliation table, is formally incorporated by reference into the company’s effective Form F-3 registration statement.

How is Exhibit 99.1 used in Burning Rock Biotech Limited’s Form F-3 registration?

The company states that Exhibit 99.1 from the Form 6-K is incorporated by reference into its Form F-3 registration statement. The incorporation excludes paragraphs under “Non-GAAP Measures,” the reconciliation table, and other discussions of non-GAAP measures, so only the remaining portions become part of that registration.

Which parts of Exhibit 99.1 are excluded from incorporation by reference for BNR?

The filing explains that paragraphs under the heading “Non-GAAP Measures,” the table titled “Burning Rock Biotech Limited Reconciliations of GAAP and Non-GAAP Results,” and other non-GAAP discussions in Exhibit 99.1 are excluded from incorporation by reference into the company’s Form F-3 registration statement.

What type of issuer is Burning Rock Biotech Limited in this Form 6-K?

Burning Rock Biotech Limited files this report as a foreign private issuer under the Securities Exchange Act of 1934. The Form 6-K indicates the company provides information to U.S. investors while primarily reporting under foreign rules, and it cross-references its annual reporting on Form 20-F.